MAHON PAUL A 4
4 · UNITED THERAPEUTICS Corp · Filed Jul 16, 2026
Research Summary
AI-generated summary of this filing
United Therapeutics (UTHR) EVP Paul A. Mahon Exercises Options, Sells Shares
What Happened
- Paul A. Mahon, EVP & General Counsel of United Therapeutics (UTHR), exercised 8,300 stock options on 2026-07-16 at a strike price of $146.03 (cost $1,212,049) and sold the 8,300 resulting shares the same day in multiple open-market trades under a pre-arranged 10b5-1 plan. The reported total sales proceeds were $4,429,637 (multiple weighted-average prices across trades).
- This sequence (exercise followed by immediate sale) is a cashless-style exercise and sale under a trading plan rather than an open-market purchase.
Key Details
- Date: 2026-07-16
- Exercise: 8,300 shares @ $146.03 = $1,212,049 (code M)
- Sales: 8,300 shares sold in multiple trades (codes S); grouped weighted-average prices reported for different blocks; total gross proceeds = $4,429,637
- Net gross spread before fees/taxes: ~$3,217,588 (proceeds minus exercise cost)
- Footnotes: F1 — transactions executed pursuant to a pre-arranged 10b5-1 plan entered Aug 11, 2025. F2–F7 — sales executed in multiple trades with reported price ranges; weighted averages shown in filing.
- Shares owned after transaction: not disclosed in the provided excerpt of the filing
- Timeliness: filing shows transactions dated and reported for 2026-07-16; no late filing flag indicated
Context
- Transaction codes: M = option exercise/conversion, S = open-market sale. Here the exercised options were converted into shares and those shares were immediately sold under the 10b5-1 plan (routine liquidity event).
- For retail investors: purchases tend to be more informative about insider sentiment; this filing documents a pre-planned exercise-and-sale, which is common for executives exercising compensation-related options.
Insider Transaction Report
Form 4
MAHON PAUL A
EVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-07-16$146.03/sh+8,300$1,212,049→ 53,472 total - Sale
Common Stock
[F1]2026-07-16$527.60/sh−600$316,557→ 52,872 total - Sale
Common Stock
[F1]2026-07-16$529.81/sh−120$63,577→ 52,752 total - Sale
Common Stock
[F1][F2]2026-07-16$531.97/sh−861$458,025→ 51,891 total - Sale
Common Stock
[F1][F3]2026-07-16$532.94/sh−800$426,352→ 51,091 total - Sale
Common Stock
[F1][F4]2026-07-16$534.21/sh−3,279$1,751,679→ 47,812 total - Sale
Common Stock
[F1][F5]2026-07-16$535.88/sh−1,041$557,851→ 46,771 total - Sale
Common Stock
[F1][F6]2026-07-16$534.99/sh−1,519$812,648→ 45,252 total - Sale
Common Stock
[F1][F7]2026-07-16$536.85/sh−80$42,948→ 45,172 total - Exercise/Conversion
Stock Option
[F1]2026-07-16−8,300→ 80,740 totalExercise: $146.03From: 2023-03-15Exp: 2027-03-15→ Common Stock (8,300 underlying)
Footnotes (7)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $531.50 to $532.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $532.51 to $533.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $533.56 to $534.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $535.565 to $536.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $534.56 to $535.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $536.75 to $536.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-07-16